查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1800865

2025 年至 2033 年动脉粥状硬化斑块切除设备市场报告（按产品应用、最终用户和地区）

Atherectomy Devices Market Report by Product Application, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球动脉粥状硬化斑块切除器械市场规模达10.224亿美元。展望未来， IMARC Group预计到2033年，该市场规模将达到15.245亿美元，2025-2033年期间的复合年增长率（CAGR）为4.31%。週边动脉疾病（PAD）发病率的上升、技术的显着进步、人口老化加剧、微创手术的出现、医疗基础设施的完善以及新兴经济体的报销政策是推动动脉粥状硬化斑块切除器械市场增长的一些关键因素。

动脉粥状硬化斑块切除设备市场趋势：

週边动脉疾病（PAD）病例不断增加

由于人口老化、糖尿病和肥胖症的增多，全球週边动脉疾病 (PAD) 病例不断增加，这推动了动脉粥状硬化斑块切除器械市场的成长。在美国，週边动脉疾病 (PAD) 影响约 800 万至 1,200 万人，尤其是 50 岁以上的人。其中，40 岁以上的患者约有 650 万人被诊断出患有周边动脉疾病 (PAD)。动脉粥状硬化斑块切除器械是一种微创方法，可去除动脉斑块，是血管介入治疗的重要替代方案。此器械可增强血流，缓解腿部疼痛和疲劳等症状。透过直接切除或汽化斑块，这些器械有助于恢復动脉通畅，显着改善重度週边动脉疾病 (PAD) 患者的预后。

技术进步

动脉粥状硬化斑块切除术的主要创新包括定向控制装置和高频旋转技术的出现，这些技术不断提高这些设备的有效性和安全性。例如，2020 年的一项研究表明，轨道式动脉粥状硬化斑块切除术（可磨除斑块）可有效疏通阻塞的腿部动脉，成功率为 90%，而雷射动脉粥样硬化斑块切除术可有效改善血流，成功率为 76%。患者预后的改善以及外科医生对这些设备的偏好正在推动动脉粥状硬化斑块切除术设备的发展。在一项针对 172 名患者的多中心研究中，Jetstream 设备的使用成功率为 99%，6 个月和 12 个月的临床驱动标靶病变血管重建率分别为 15% 和 26%；基于双功能成像，一年内再狭窄率为 38%。

拓展新兴市场

知名的关键参与者正聚焦于医疗基础设施建设和医疗支出不断增长的新兴经济体，从而为市场关键参与者创造新的机会。例如，巴西、俄罗斯、印度、中国和南非（金砖国家）等新兴市场正日益塑造全球卫生领域对医疗产品和服务的供需格局。预计2030年医疗支出将占GDP的比重为：巴西8.4%；俄罗斯5.2%；印度3.5%；中国5.9%；南非10.4%。更先进的治疗方案的实现使得这些市场的渗透成为可能，从而扩大了动脉粥状硬化斑块切除设备的全球覆盖范围。

动脉粥状硬化斑块切除设备市场细分：

按产品分类：

  • 定向旋磨装置
  • 眼眶动脉粥状硬化斑块切除装置
  • 光消融斑块切除设备
  • 旋磨设备
  • 支援设备

定向动脉粥状硬化切除术设备占据大部分市场份额

定向动脉粥状硬化斑块切除术 (DCC) 设备旨在精准清除阻塞动脉中的动脉粥状硬化斑块。这些设备能够实现精准控制，从而减少血管壁损伤，这对患者的安全和復原至关重要。其能够治疗多种血管大小的复杂病变，深受血管专科医生的青睐，并推动了该产品细分市场的成长。这些设备在手术过程中能够收集和清除斑块，使其脱颖而出，在许多临床情况下更受青睐。

按应用分类：

  • 週边血管
  • 心血管
  • 神经血管

週边血管占据大部分市场份额

由于週边动脉疾病 (PAD) 的发生率不断上升，使用动脉粥状硬化斑块切除器械治疗週边血管疾病至关重要。此类器械在重建腿部动脉血流方面发挥关键作用，有助于缓解疼痛和行动不便等症状。该领域的需求源自于其微创特性，与传统手术相比，该手术恢復期短，併发症风险低，从而提高了患者的治疗效果和治疗效率。

按最终用户分类：

  • 医院
  • 门诊手术中心
  • 研究实验室和学术机构

医院占大部分市场份额

医院是动脉粥状硬化斑块切除术设备的主要用户，因为这些手术非常复杂，需要先进的基础设施和训练有素的医疗保健专业人员。随着该细分市场的成长，医院血管手术数量的成长也随之而来，这得益于对先进技术和医疗服务提供者培训计画的投资。医院能够提供包括术后护理在内的各类护理，也使其成为市场中的主导力量。

按地区划分：

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

北美占据市场主导地位

该报告还对所有主要市场进行了全面分析，包括北美（美国、加拿大）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；拉丁美洲（巴西、墨西哥等）以及中东和非洲。报告指出，北美是最大的动脉粥状硬化切除设备市场。

北美是动脉粥状硬化斑块切除术最大的市场，因为该地区心血管疾病盛行率高、医疗保健体系发达且拥有许多关键市场参与者。美国是该地区最大的市场，因为其报销方案优惠、临床试验充足，并且政府对先进医疗器材研发给予了大力支持。该地区对新型医疗保健解决方案应用的投入正在推动市场成长。

（请注意，这只是关键参与者的部分列表，完整列表在报告中提供。）

  • 动脉粥状硬化斑块切除设备市场充满活力，主要参与者不断采用不同的策略，以扩大市场份额并满足市场对微创手术替代方案日益增长的需求。其中一个策略是技术导向，即公司在研发方面投入巨资，改善其设备，使其更有效率、更安全。第二种常见策略是建立策略联盟与合作关係，以支援知识共享和更优的通路。此外，併购也很常见，这使得公司能够扩大产品组合和地理覆盖范围。监管机构的批准在其中发挥着重要作用，因为公司正努力满足严格的规范，以确保其产品在众多市场的高效性和安全性。

本报告回答的关键问题

  • 2024 年全球动脉粥状硬化切除设备市场规模是多少
  • 2025 年至 2033 年期间全球动脉粥状硬化切除设备市场的预期成长率是多少
  • COVID-19 对全球动脉粥状硬化切除设备市场有何影响
  • 推动全球动脉粥状硬化切除设备市场的关键因素有哪些
  • 根据产品类型，全球动脉粥状硬化切除设备市场如何划分？
  • 根据应用，全球动脉粥状硬化切除设备市场如何划分
  • 根据最终用户，全球动脉粥状硬化切除设备市场如何划分
  • 全球动脉粥状硬化切除设备市场的主要区域有哪些
  • 全球动脉粥状硬化切除设备市场的主要参与者/公司有哪些

本报告回答的关键问题

  • 2024年全球动脉粥状硬化斑块切除设备市场规模？ 2025年至2033年期间，全球动脉粥状硬化斑块切除设备市场的预期成长率为何？
  • COVID-19 对全球动脉粥状硬化切除设备市场有何影响？
  • 推动全球动脉粥状硬化切除设备市场发展的关键因素有哪些？
  • 根据产品，全球动脉粥状硬化切除设备市场是如何分布的？
  • 根据应用，全球动脉粥状硬化切除设备市场是如何分布的？
  • 根据最终用户，全球动脉粥状硬化切除设备市场是如何分布的？
  • 全球动脉粥状硬化切除设备市场的主要区域有哪些？
  • 全球动脉粥状硬化切除设备市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球动脉粥状硬化切除设备市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品

  • 定向旋磨装置
  • 眼眶动脉粥状硬化斑块切除装置
  • 光消融斑块切除设备
  • 旋磨设备
  • 支援设备

第七章：市场区隔：依应用

  • 週边血管
  • 心血管
  • 神经血管

第八章：市场区隔：按最终用户

  • 医院
  • 门诊手术中心
  • 研究实验室和学术机构

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第十章：SWOT分析

第 11 章：价值链分析

第 12 章：波特五力分析

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • Avinger
    • B. Braun Melsungen AG
    • Biomerics
    • Biotronik
    • Boston Scientific Corporation
    • CR Bard (Becton, Dickinson and Company)
    • Cardinal Health Inc.
    • Koninklijke Philips NV
    • Medtronic
    • Minnetronix Inc.
    • Straub Medical AG (Becton, Dickinson and Company)
    • Terumo Corporation
Product Code: SR112025A2766

The global atherectomy devices market size reached USD 1,022.4 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,524.5 Million by 2033, exhibiting a growth rate (CAGR) of 4.31% during 2025-2033. The rise in peripheral artery disease (PAD), significant technological advancements, rising ageing population, advent of minimally invasive surgeries, development of healthcare infrastructure, and reimbursement policies in emerging economies represent some of the key factors driving the growth of the atherectomy market.

Atherectomy Devices Market Trends:

Rising Cases of Peripheral Artery Disease (PAD)

The increasing cases of PAD at a global level due to ageing population and the rise in diabetes and obesity is leading the atherectomy device market growth. Approximately, PAD affects 8 to 12 million people in the United States, especially in those over 50. Out of these, 6.5 million over the age of 40 are diagnosed with PAD. Atherectomy devices provide a minimally invasive approach to remove arterial plaque as it is an important alternative in vascular interventions. The device enhances blood flow and reduces symptoms such as leg pain and fatigue. By directly cutting away or vaporizing the plaque, these devices help restore arterial patency, significantly improving patient outcomes in individuals with severe forms of PAD.

Technological Advancements

Major atherectomy devices innovations include the appearance of directionally controlled devices and high-frequency rotational technologies, which have continued to improve the effectiveness and safety of these devices. For instance, a 2020 study suggests that orbital atherectomy (which sands down plaque) effectively opens up blocked leg arteries 90 percent of the time, while laser atherectomy achieves similarly improved blood flow 76 percent of the time. These improvements in patient outcome and surgeon preference for these devices are propelling the growth of the atherectomy devices. In a multicenter study of 172 patients, Jetstream use had a 99% device success, and six-month and 12-month clinically-driven, target-lesion revascularization rates of 15% and 26%, respectively; with a one-year restenosis rate of 38% based on duplex imaging.

Expansion into Emerging Markets

Prominent key players are focusing on emerging economies where healthcare infrastructure development and growing healthcare spending is focused, thereby creating new opportunities for the key players in the market. For instance, the emerging markets of Brazil, Russia, India, China, and South Africa (BRICS) are increasingly shaping the landscape of the global health sector demand and supply for medical goods and services. Health spending as a percentage of GDP in 2030 is projected as - Brazil, 8.4%; Russia, 5.2%; India, 3.5%; China, 5.9%; South Africa, 10.4%. The penetration into these markets is enabled by realization of more advanced treatment alternatives, thus expanding the global footprint of atherectomy devices.

Atherectomy Devices Market Segmentation:

Breakup by Product:

  • Directional Atherectomy Devices
  • Orbital Atherectomy Devices
  • Photo-Ablative Atherectomy Devices
  • Rotational Atherectomy Devices
  • Support Devices

Directional Atherectomy Devices accounts for the majority of the market share

Directional atherectomy devices are created to precisely eliminate atherosclerotic plaque from obstructed arteries. These instruments provide the possibility of accurate control, which reduces vessel wall trauma, an important aspect for patient safety and recovery. Their ability to treat complex lesions in multiple vessel sizes makes them to be favoured by vascular specialists leading to the growth of the product segment. The capability of the devices to collect and remove plaque during the procedure sets these devices apart and is in a number of clinical situations preferable.

Breakup by Application:

  • Peripheral Vascular
  • Cardiovascular
  • Neurovascular

Peripheral Vascular accounts for the majority of the market share

The use of atherectomy devices in the treatment of peripheral vascular diseases is important because of the growing prevalence of PAD. Such devices play a key role in reestablishing the blood flow in leg arteries thus help to relieve the symptoms such as pain and mobility problems. The demand in this segment is determined by minimally invasive character of the procedure which allows short recovery period and lower risks of complications in comparison to conventional surgery making patient outcomes and treatment efficiencies higher.

Breakup by End User:

  • Hospitals
  • Ambulatory Surgery Centers
  • Research Laboratories and Academic Institutes

Hospitals accounts for the majority of the market share

Hospitals are the main users of atherectomy devices because these procedures are very complex and need advanced infrastructure and highly trained healthcare professionals. The growth of the segment is followed by the growth of the number of vascular surgeries conducted in hospitals, fueled by investments into advanced technologies and in the training programs of health providers. Ability of hospitals to offer all types of care including post-operative requirements also helps in making them the dominant subject in the market.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America dominates the market

The report has also provided a comprehensive analysis of all the major markets which include North America (United States, Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others); Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others); Latin America (Brazil, Mexico, Others), and Middle East and Africa. According to the report, North America was the largest market for atherectomy devices.

North America is the largest market for atherectomy because of high prevalence of cardiovascular diseases, developed healthcare system and the key market players in the region. The United States is the biggest market in this region because of the favourable reimbursement scenarios, clinical trials, and solid governmental support for research and development in advanced medical devices. The commitment of the region to application of new healthcare solutions is driving the market growth.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have been provided. Some of the major market players in the atherectomy devices market include Abbott Laboratories, Avinger, B. Braun Melsungen AG, Biomerics, Biotronik, Boston Scientific Corporation, C.R. Bard (Becton, Dickinson and Company), Cardinal Health, Koninklijke Philips N.V., Medtronic, Minnetronix Inc., Straub Medical AG (Becton, Dickinson and Company), and Terumo Corporation.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

  • There is a dynamic market in atherectomy devices with the use of evolving strategies by major players in pursuit to grow their market share and to satisfy the increasing demand for minimally invasive surgery alternatives. One of these approaches is technical oriented, which is to say that the companies invest significantly in R&D to improve their devices that become therefore more efficient and safer. The second common event is strategic alliances and collaborations that support knowledge sharing and better distribution channels. In addition, mergers and acquisitions are common enabling companies to expand their product portfolios and geographical coverage. Approvals by regulatory bodies play an important role here as the companies are trying to meet tough norms that guarantee the efficiency and safety of their products in many markets.

Key Questions Answered in This Report

  • 1.What was the size of the global atherectomy devices market in 2024?
  • 2.What is the expected growth rate of the global atherectomy devices market during 2025-2033?
  • 3.What has been the impact of COVID-19 on the global atherectomy devices market?
  • 4.What are the key factors driving the global atherectomy devices market?
  • 5.What is the breakup of the global atherectomy devices market based on the product?
  • 6.What is the breakup of the global atherectomy devices market based on the application?
  • 7.What is the breakup of the global atherectomy devices market based on the end user?
  • 8.What are the key regions in the global atherectomy devices market?
  • 9.Who are the key players/companies in the global atherectomy devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Atherectomy Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Directional Atherectomy Devices
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Orbital Atherectomy Devices
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Photo-Ablative Atherectomy Devices
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Rotational Atherectomy Devices
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Support Devices
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Peripheral Vascular
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cardiovascular
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Neurovascular
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgery Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Research Laboratories and Academic Institutes
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Avinger
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 B. Braun Melsungen AG
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Biomerics
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Biotronik
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Boston Scientific Corporation
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 C.R. Bard (Becton, Dickinson and Company)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Cardinal Health Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Koninklijke Philips N.V.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Medtronic
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Minnetronix Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Straub Medical AG (Becton, Dickinson and Company)
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
    • 14.3.13 Terumo Corporation
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Atherectomy Devices Market: Major Drivers and Challenges
  • Figure 2: Global: Atherectomy Devices Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Atherectomy Devices Market: Breakup by Product (in %), 2024
  • Figure 4: Global: Atherectomy Devices Market: Breakup by Application (in %), 2024
  • Figure 5: Global: Atherectomy Devices Market: Breakup by End User (in %), 2024
  • Figure 6: Global: Atherectomy Devices Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 8: Global: Atherectomy Devices (Directional Atherectomy Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Atherectomy Devices (Directional Atherectomy Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Atherectomy Devices (Orbital Atherectomy Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Atherectomy Devices (Orbital Atherectomy Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Atherectomy Devices (Photo-Ablative Atherectomy Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Atherectomy Devices (Photo-Ablative Atherectomy Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Atherectomy Devices (Rotational Atherectomy Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Atherectomy Devices (Rotational Atherectomy Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Atherectomy Devices (Support Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Atherectomy Devices (Support Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Atherectomy Devices (Peripheral Vascular) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Atherectomy Devices (Peripheral Vascular) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Atherectomy Devices (Cardiovascular) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Atherectomy Devices (Cardiovascular) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Atherectomy Devices (Neurovascular) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Atherectomy Devices (Neurovascular) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Atherectomy Devices (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Atherectomy Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Atherectomy Devices (Ambulatory Surgery Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Atherectomy Devices (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Atherectomy Devices (Research Laboratories and Academic Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Atherectomy Devices (Research Laboratories and Academic Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: North America: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: North America: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: United States: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: United States: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Canada: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Canada: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Asia Pacific: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Asia Pacific: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: China: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: China: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Japan: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Japan: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: India: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: India: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: South Korea: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: South Korea: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Australia: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Australia: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Indonesia: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Indonesia: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Others: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Others: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Europe: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Europe: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Germany: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Germany: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: France: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: France: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: United Kingdom: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: United Kingdom: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Italy: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Italy: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Spain: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Spain: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Russia: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Russia: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Latin America: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Latin America: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Brazil: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Brazil: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Mexico: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Mexico: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Middle East and Africa: Atherectomy Devices Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Middle East and Africa: Atherectomy Devices Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Global: Atherectomy Devices Industry: SWOT Analysis
  • Figure 79: Global: Atherectomy Devices Industry: Value Chain Analysis
  • Figure 80: Global: Atherectomy Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Atherectomy Devices Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Atherectomy Devices Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Atherectomy Devices Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Atherectomy Devices Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Atherectomy Devices Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Atherectomy Devices Market: Competitive Structure
  • Table 7: Global: Atherectomy Devices Market: Key Players